Cholestatic attack due to ampicillin and cross-reactivity to cefuroxime [3]

Annals of Pharmacotherapy

Volumn 38, Issue 9, 2004, Pages 1539-1540

  Köklü, Seyfettin ^a   Yüksel, Osman ^a   Yolcu, Ömer Faruk ^a   Arhan, Mehmet ^a   Altiparmak, Emin ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFUROXIME; CEPHALOSPORIN DERIVATIVE;

ADULT; ANTIBIOTIC THERAPY; CASE REPORT; CHOLESTASIS; CROSS REACTION; DRUG INDUCED DISEASE; HUMAN; INFECTION; LETTER; LIVER INJURY; MALE; MOUTH ABSCESS; PRIORITY JOURNAL; TOOTH INFECTION; TOXIC HEPATITIS;

ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; CEFUROXIME; CHOLESTASIS; CROSS REACTIONS; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE;

EID: 4143079090     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E025     Document Type: Letter

References (6)

1. Köklü S, Yüksel O, Filik L, Üsküdar O, Altundǎg K, Altiparmak E. Recurrent cholestasis due to ampicillin. Ann Pharmacother 2003;37:395-7. DOI 10.1345/aph.1C273
2. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
3. Westphal JF, Vetter D, Brogard JM. Hepatic side-effects of antibiotics. J Antimicrob Chemother 1994;33:387-401.
4. Ammann R, Neftel K, Hardmeier T, Reinhardt M. Cephalosporin-induced cholestatic jaundice. Lancet 1982;2:336-7.
5. Kishiyama JL, Adelman DC. The cross-reactivity and immunology of β-lactam antibiotics. Drug Saf 1994;10:318-27.
6. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995;74:167-70.